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The	   aim	   of	   Marine	   Fungi	   is	   to	   evaluate	   the	   poten1al	   of	   secondary	  
metabolites	  from	  fungi	  associated	  with	  marine	  macro-­‐organisms	  to	  provide	  
lead	   compounds	   for	   the	   development	   of	   cancer	   treatments.	   Extracts	   from	  
fermenta1ons	   of	   fungi	   isolated	   from	   Mediterranean	   sponges,	   Indonesian	  
corals	  and	  Chilean	  macroalgae	  were	  screened	  against	  a	  preliminary	  cell	  line	  
panel	  comprising	  the	  786-­‐0,	  M14	  and	  MCF-­‐7	  tumour	  cell	  lines.	  Extracts	  from	  
fermenta1ons	   of	   the	   sponge-­‐associated	   strain	   MF458,	   subsequently	  
iden1ﬁed	  as	  Tolypocladium	  geodes,	  were	  found	  to	  have	  potent	  an1-­‐tumour	  
eﬀects	   with	   predominantly	   an1-­‐prolifera1ve	   rather	   than	   overtly	   cytotoxic	  
proﬁles.	   Assay-­‐guided	   puriﬁca1on	   and	   structural	   characterisa1on	   has	  
revealed	   the	   presence	   of	   compounds	   expressed	   by	   ﬁve	   diﬀerent	  
biosynthe1c	   pathways.	   While	   some	   of	   these	   have	   been	   iden1ﬁed	   as	  
compounds	   known	   to	   have	   eﬀects	   on	   mammalian	   cells	   –	   pyridoxa1n,	  
cyclosporins	   and	   efrapep1ns	   –	   other	   minor	   components	   are	   new	  
compounds	  that	  have	  not	  previously	  been	  described,	  and	  their	  an1-­‐tumour	  
proper1es	  are	  being	  assessed.	  
Tolypocladium	   geodes	  MF458	   was	   isolated	   from	   a	   Mediterranean	   sponge	  
(Tethya	   auran6um)	   	   and	   iden1ﬁed	   by	   morphological	   and	   molecular	  
characterisa1on.	  The	  strain	  was	  cul1vated	  in	  a	  variety	  of	  media	   in	  order	  to	  
characterise	   the	  metabolite	   spectrum	  of	   this	   strain.	   	   The	   best	   an1tumour	  
ac1vity	   in	   extracts	  was	   found	   following	   cul1va1on	  on	  Wickerham	  medium	  
containing	  30	  g/L	  tropic	  marine	  salt.	  	  
HPLC-­‐MS	  analysis	  of	  ethyl	  acetate	  extract	  of	  MF458	  Fermenta1on:	  ELSD	  chromatogram	  (top),	  diode	  array	  UV-­‐visual	  chromatogram	  (200-­‐500	  nm)	  bo]om.	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Cell	  Line	   MF458-­‐2	   MF458-­‐3	   MF458-­‐4	  
Efrapep:n	  









786-­‐0	   22	   17	   -­‐	   4	   75	   -­‐	  
DU-­‐145	   41	   32	   -­‐	   5	   106	   12	  
HL60	   26	   14	   -­‐	   4	   130	   -­‐	  
M14	   14	   17	   1.4	   4	   150	   12	  
MCF-­‐7	   16	   14	   0.05	   0.9	   56	   12	  
UO-­‐31	   53	   35	   -­‐	   5	   71	   20	  
SF539	   19	   9	   1.6	   5	   150	   11	  
TK10	   25	   7	   0.5	   15	   140	   14	  
MDA-­‐
MB-­‐468	  
18	   6	   -­‐	   0.8	   110	   4	  
OVCAR-­‐3	   15	   7	   -­‐	   0.7	   56	   -­‐	  
Growth	  Inhibitory	  Eﬀects	  (GI50s	  in	  µM)	  of	  MF458	  
Compounds	  on	  Selected	  Human	  Tumour	  Cell	  Lines	  
Discusssion	  
Tolypocladium	  geodes	  MF458,	   isolated	   from	   the	   sponge	  Tethya	  
auran6um,	   is	   a	   proliﬁc	   producer	   of	   secondary	  metabolites	   and	  
we	  have	  puriﬁed	  and	   structurally	   characterised	   the	   compounds	  
with	  an1-­‐tumour	  eﬀects	  expressed	  by	  ﬁve	  diﬀerent	  biosynthe1c	  
pathways	   under	   one	   par1cular	   set	   of	   fermenta1on	   condi1ons.	  
Compounds	   produced	   by	   employing	   diﬀerent	   fermenta1on	  
condi1ons	   represent	   a	   future	   avenue	   of	   explora1on.	  
Tolypocladium	   spp.	   have	   a]racted	   signiﬁcant	   a]en1on	   as	  
producers	  of	  bioac1ve	  secondary	  metabolites.	  The	  efrapep1ns,1	  
pyridoxa1n5	   and	   terricolin5	   have	   previously	   been	   reported	   as	  
products	  of	  terrestrial	   isolates	  of	  T.	  geodes,	  while	  produc1on	  of	  
cyclosporins	  is	  usually	  associated	  with	  other	  Tolypocladium	  spp.6	  
Metabolites	   from	  marine	   Tolypocladium	   spp.,	   such	   as	   the	   new	  
efrapep1n	  J,	  are	  also	  being	  reported.2	  	  
Extracts	  of	  MF458	  fermenta1ons	  had	  potent	  an1-­‐tumour	  eﬀects	  
with	  a	  predominantly	  an1-­‐prolifera1ve	  ac1vity	  proﬁle.	  We	  used	  
an	  assay-­‐guided	  puriﬁca1on	  approach	  to	  characterise	  the	  ac1ve	  
compounds.	   The	   most	   potent	   ac1vi1es	   found	   were	   due	   to	  
compounds	  known	  to	  have	  an1-­‐tumour	  eﬀects:	  efrapep1ns	  and	  
pyridoxa1n.	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Pharmacological	  Relevance	  NCI60	  panel	  
•  	  Compound	  A	  is	  known	  selec1ve	  kinase	  inhibitor	  against	  VEGFR2	  
•  	  RPMI-­‐8226	  cells	  express	  VEGFR2	  
•  	  NCI-­‐	  panel	  wide	  screen	  gives	  provisional	  indica1on	  of	  underlying	  target	  
Non-­‐Cancer	  cell	  line	  control	  (W138	  ﬁbroblast,	  lung	  epithelium)	  GI50	  >	  100uM	  
We	   also	   found	   new	   molecules.	   The	   novel	   acyltetramates	  
MF458-­‐7	   and	   MF458-­‐8	   only	   had	   very	   moderate	   an1-­‐tumour	  
potency.	  MF458-­‐2	   and	  MF458-­‐3	   have	  more	   potent	   eﬀects	   and	  
are	   being	   evaluated	   further.	   This	  work	   shows	   that	   new	  marine	  
isolates	   of	   even	   previously	   well-­‐researched	   species	   have	   the	  
poten1al	   to	   produce	   new	   compounds	   with	   poten1ally	   useful	  
biological	  ac1vi1es.	  
	  For	  assay	  methods,	  see	  reference.7	  
•  Pyridoxa1n:	   ﬁrst	   isolated	  
from	   Acremonium	   sp.	  
BX-­‐864	   and	   subsequently	  
from	   T.	   geodes.5	   Known	  
to	   be	   cytotoxic	   to	   HeLa	  
cells	  
•  MF458-­‐2&3	  
•  New	   molecules	  
(MWs	  <300).	  
•  	   An1-­‐tumour	  
poten1al	   under	  
evalua1on	  
•  Terricolin:	   (pyridoxa1n)3Fe	   complex	  
known	  to	  be	  produced	  by	  T.	  geodes.
5	  
•  Novel	  acyltetramates:	  structures	  elucidated	  by	   interpreta1on	  of	  1H,	  13C,	  
COSY,	  HSQC,	  HMBC	  and	  NOESY	  NMR	  spectra	  
•  MF458-­‐7	  showed	  more	  tumour	  growth	  inhibitory	  potency	  than	  MF458-­‐8	   •  Major	   metabolite	   present	   in	   these	  
fermenta1on:	  cyclosporin	  A	  
•  Known	   Tolypocladium	   spp.	  
metabolite.6	  
•  Efrapep1n	   D	   or	   J.	   Efrapep1ns	   have	   potent	   an1-­‐tumour	   eﬀects	  	  
resul1ng	  from	  inhibi1on	  of	  	  mitochondrial	  F1F0-­‐ATPase	  and	  down-­‐
regula1on	  of	  HSP90	  chaperone	  ac1vity.1-­‐3	  
1	  
2	  
3	  
